DSM : dsm-firmenich's PARSOL Shield marks major milestone with FDA submission for OTC sunscreen monograph

In an interview with CosmeticsDesign, Carl Ruiz, Senior Regulatory & Business Development Manager at dsm-firmenich explained that the FDA review of PARSOL Shield could transform the US sunscreen market by meeting the need for a more photostable UVA and UVB filter, offering manufacturers the first new sunscreen active ingredient since 1999.